Home »
Hyperphosphatemia Global Clinical Trials Review, Q2, 2011

Hyperphosphatemia Global Clinical Trials Review, Q2, 2011

Double click on above image to view full picture

Email to a Colleague - Print - Fax Order

Additional Information

Price	$1,000.00
Publisher	GlobalData
Date of Report	Jun 15, 2011

Add to Wishlist | Add to Compare

Qty:

-OR-

Quick Overview

Hyperphosphatemia Global Clinical Trials Review, Q2, 2011

Summary

GlobalData's clinical trial report, “Hyperphosphatemia Global Clinical Trials Review, Q2, 2011" provides data on the Hyperphosphatemia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hyperphosphatemia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Hyperphosphatemia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Hyperphosphatemia 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by BRIC Nations 16
Clinical Trials by Phase 17
In Progress Trials by Phase 18
Clinical Trials by Trial Status 19
Unaccomplished Trials of Hyperphosphatemia 20
Subjects Recruited Over a Period of Time 21
Prominent Sponsors 22
Top Companies Participating in Hyperphosphatemia Therapeutics Clinical Trials 24
Prominent Drug Comparison 26
Clinical Trial Profiles 27
Clinical Trial Overview of Top Companies 27
Mitsubishi Tanabe Pharma Corporation 27
Clinical Trial Overview of Mitsubishi Tanabe Pharma Corporation 27
INEOS Healthcare Ltd. 28
Clinical Trial Overview of INEOS Healthcare Ltd. 28
Keryx Biopharmaceuticals, Inc. 29
Clinical Trial Overview of Keryx Biopharmaceuticals, Inc. 29
Bayer AG 30
Clinical Trial Overview of Bayer AG 30
Genzyme Corporation 31
Clinical Trial Overview of Genzyme Corporation 31
Astellas Pharma Inc. 32
Clinical Trial Overview of Astellas Pharma Inc. 32
Novartis AG 33
Clinical Trial Overview of Novartis AG 33
Shire Pharmaceutical Development Inc. 34
Clinical Trial Overview of Shire Pharmaceutical Development Inc. 34
Nephrian, Inc 35
Clinical Trial Overview of Nephrian, Inc 35
KDL GmbH 36
Clinical Trial Overview of KDL GmbH 36
Ilypsa, Inc. 37
Clinical Trial Overview of Ilypsa, Inc. 37
Nabi Biopharmaceuticals 38
Clinical Trial Overview of Nabi Biopharmaceuticals 38
Abbott Laboratories 39
Clinical Trial Overview of Abbott Laboratories 39
Clinical Trial Overview of Top Universities / Institutes / Hospitals 40
Fresenius Medical Care North America 40
Clinical Trial Overview of Fresenius Medical Care North America 40
University of Illinois 41
Clinical Trial Overview of University of Illinois 41
Washington University School of Medicine 42
Clinical Trial Overview of Washington University School of Medicine 42
Denver Nephrology 43
Clinical Trial Overview of Denver Nephrology 43
COLC Study Research group 44
Clinical Trial Overview of COLC Study Research group 44
Shigei Medical Research Hospital. 45
Clinical Trial Overview of Shigei Medical Research Hospital. 45
Phosphate Research group 46
Clinical Trial Overview of Phosphate Research group 46
University of Miyazaki Hospital 47
Clinical Trial Overview of University of Miyazaki Hospital 47
Taipei Medical University WanFang Hospital 48
Clinical Trial Overview of Taipei Medical University WanFang Hospital 48
Romanian Society of Nephrology 49
Clinical Trial Overview of Romanian Society of Nephrology 49
Brigham and Women's Hospital 50
Clinical Trial Overview of Brigham and Women's Hospital 50
Shanghai Jiao Tong University 51
Clinical Trial Overview of Shanghai Jiao Tong University 51
Kobe University 52
Clinical Trial Overview of Kobe University 52
Karolinska Institutet 53
Clinical Trial Overview of Karolinska Institutet 53
MetroHealth Medical Center 54
Clinical Trial Overview of MetroHealth Medical Center 54
Assistance Publique - Hopitaux de Paris 55
Clinical Trial Overview of Assistance Publique - Hopitaux de Paris 55
Appendix 56
Abbreviations 56
Definitions 56
Research Methodology 57
Secondary Research 57
About GlobalData 58
Contact Us 58
Disclaimer 58
Source 58